[1]
Vishnupriya S, Andhuvan G, Saravanan T, and Velammal P, “A comparative study on the effect of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors as an add on therapy in patients with type 2 DM”, Int. J. Res. Pharm. Sci., vol. 11, no. 1, pp. 630–634, Jan. 2020.